Skip to content

Aquestive Therapeutics, Inc. AQST Balance Sheet Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$110.73M+61.3%$121.17M+69.4%$129.06M+65.7%$60.54M-32.6%$68.66M-27.9%
$8.07M+12.1%$6.17M+2.1%$7.88M+12.3%$8.13M+16.6%$7.2M-6.9%
$130.18M+46.0%$149.27M+69.2%$151.67M+57.1%$81.72M-21.4%$89.17M-21.4%
$3.84M+1.0%$3.89M+2.5%$3.92M+1.8%$3.86M-1.6%$3.8M-6.1%
$141.13M+38.0%$160.43M+58.2%$163.56M+48.7%$93.7M-20.3%$102.23M-21.1%
$11.89M-3.2%$29.86M+190%$10.87M+43.5%$11.95M+110%$12.28M+16.7%
$1.09M+4.2%$1.09M+4.2%$1.09M+4.2%$1.09M+4.4%$1.05M-32.4%
$14.54M+52.4%$9.54M$9.54M$9.54M$9.54M
$31.75M+73.5%$47.61M+152%$25.57M+68.8%$23.16M+66.6%$18.3M+1.3%
$45M0.0%$45M0.0%$45M0.0%$45M0.0%$45M0.0%
$175.18M+7.4%$194.09M+20.1%$167.67M+7.9%$166.29M+8.6%$163.16M-1.6%
250M0.0%250M0.0%250M0.0%250M0.0%250M0.0%
-$455.06M-17.8%-$447M-23.1%-$415.14M-19.9%-$399.69M-19.4%-$386.14M-16.3%
-$34.05M+44.1%-$33.66M+44.0%-$4.11M+91.0%-$72.59M-105%-$60.93M-67.8%
$141.13M+38.0%$160.43M+58.2%$163.56M+48.7%$93.7M-20.3%$102.23M-21.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Aquestive Therapeutics, Inc.'s total assets?
Aquestive Therapeutics, Inc. (AQST) holds $141.1M in total assets, up 38.0% year over year.
How much debt does Aquestive Therapeutics, Inc. have?
Aquestive Therapeutics, Inc. carries $64.4M in total debt against -$34.1M of shareholders' equity, a debt-to-equity ratio of -1.89.
How much cash does Aquestive Therapeutics, Inc. have?
Aquestive Therapeutics, Inc. holds $110.7M in cash and equivalents.
Can Aquestive Therapeutics, Inc. cover its short-term obligations?
Its current ratio is 4.10 — current assets exceed current liabilities.
Where does Aquestive Therapeutics, Inc.'s balance sheet data come from?
Every line is extracted from Aquestive Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.